The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters
The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters

Novavax coronavirus vaccine highly effective, but not against South Africa variant

  • The US biotech firm said the product showed 89.3 per cent efficacy in a phase 3 trial in Britain
  • Novavax says it will begin developing a new vaccine to target the highly infectious strain first found in South Africa

Topic |   Coronavirus pandemic
The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters
The British Novavax trial involved 15,000 people age 18 to 84, including 27 per cent who were over the age of 65. Photo: Reuters
READ FULL ARTICLE